Yumin Wang

3.8k total citations · 5 hit papers
122 papers, 2.4k citations indexed

About

Yumin Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yumin Wang has authored 122 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Yumin Wang's work include RNA modifications and cancer (15 papers), Cryptography and Data Security (14 papers) and Ferroptosis and cancer prognosis (13 papers). Yumin Wang is often cited by papers focused on RNA modifications and cancer (15 papers), Cryptography and Data Security (14 papers) and Ferroptosis and cancer prognosis (13 papers). Yumin Wang collaborates with scholars based in China, United States and Taiwan. Yumin Wang's co-authors include Hongquan Wang, Jichao Chen, Yulin Li, Wailong Zou, Jinhua Wang, Joshua S. Fleishman, Ren Zhao, Shuang Wu, Luyuan Zhang and Qiang Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Yumin Wang

112 papers receiving 2.3k citations

Hit Papers

Overcoming cancer chemotherapy resistance by the inductio... 2022 2026 2023 2024 2022 2023 2023 2023 2023 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Overcoming cancer chemotherapy resistance by the induction of ferroptosis
    2022 220 citations Yumin Wang, Jichao Chen et al. Drug Resistance Updates profile →
  2. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
    2023 140 citations Yumin Wang, Yongming Chen et al. Drug Resistance Updates profile →
  3. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
    2023 110 citations Yumin Wang, Shuang Wu et al. profile →
  4. Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
    2023 107 citations Yumin Wang, Shuang Wu et al. profile →
  5. Epigenetic modification of m6A regulator proteins in cancer
    2023 104 citations Yumin Wang, Yan Wang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumin Wang China 25 1.3k 573 503 257 150 122 2.4k
Wanpeng Yu China 25 1.6k 1.3× 950 1.7× 505 1.0× 221 0.9× 158 1.1× 48 2.3k
Le Su China 29 1.5k 1.2× 596 1.0× 303 0.6× 235 0.9× 303 2.0× 139 2.7k
Chao Duan China 22 761 0.6× 329 0.6× 184 0.4× 189 0.7× 177 1.2× 102 1.8k
Ning Liu China 31 1.3k 1.1× 494 0.9× 220 0.4× 413 1.6× 295 2.0× 189 3.0k
Yihui Yang China 22 933 0.7× 499 0.9× 289 0.6× 320 1.2× 183 1.2× 100 2.0k
Min Xu China 29 767 0.6× 366 0.6× 706 1.4× 451 1.8× 261 1.7× 135 2.6k
Hui Luo China 29 1.2k 1.0× 608 1.1× 352 0.7× 470 1.8× 263 1.8× 126 2.8k
Jifa Zhang China 27 1.6k 1.3× 297 0.5× 249 0.5× 448 1.7× 186 1.2× 98 2.6k

Countries citing papers authored by Yumin Wang

Since Specialization
Citations

This map shows the geographic impact of Yumin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Wang more than expected).

Fields of papers citing papers by Yumin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Wang. The network helps show where Yumin Wang may publish in the future.

Co-authorship network of co-authors of Yumin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yumin Wang. A scholar is included among the top collaborators of Yumin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumin Wang. Yumin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaomeng, Zhe Li, Jiaqian Wang, et al.. (2025). A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-β-MHC-I axis. Drug Resistance Updates. 81. 101252–101252. 3 indexed citations
2.
Wang, Yumin, Shuang Wu, Xuan Zhang, et al.. (2025). cGAS-STING and autophagy: crosstalk, molecular mechanisms, and targeted therapy. Archives of Toxicology. 100(1). 145–172. 2 indexed citations
3.
Zhang, Junjing, et al.. (2025). Small Molecules Targeting Non-Coding RNAs Regulating Ferroptosis: New Opportunities in Precision Cancer Therapy. Antioxidants and Redox Signaling. 43(4-6). 345–362.
4.
Wang, Yumin, et al.. (2024). Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 176. 116878–116878. 5 indexed citations
5.
Wang, Hongquan, Joshua S. Fleishman, Sihang Cheng, et al.. (2024). Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance. Molecular Cancer. 23(1). 177–177. 32 indexed citations
6.
Wang, Hongquan, Shuang Wu, Xiaodong Jiang, et al.. (2024). Acteoside alleviates salsolinol-induced Parkinson's disease by inhibiting ferroptosis via activating Nrf2/SLC7A11/GPX4 pathway. Experimental Neurology. 385. 115084–115084. 8 indexed citations
7.
Wang, Yumin, Joshua S. Fleishman, Yulin Li, et al.. (2024). Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review). International Journal of Oncology. 66(1). 7 indexed citations
8.
9.
Wang, Yumin, Yongming Chen, Junjing Zhang, et al.. (2023). Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance. Drug Resistance Updates. 72. 101018–101018. 140 indexed citations breakdown →
10.
Yang, Haibo, Yumin Wang, Yufei Xiang, et al.. (2022). FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation. Proceedings of the National Academy of Sciences. 119(12). e2116251119–e2116251119. 102 indexed citations
11.
Du, Lutao, Li Yang, Maoxiao Feng, et al.. (2021). USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization. Cancer Research. 81(14). 3822–3834. 108 indexed citations
12.
Zhang, Mingxing, Chengyu Liang, Junchang Chen, et al.. (2021). Intrinsic Semiconducting Behavior in a Large Mixed‐Valent Uranium(V/VI) Cluster. Angewandte Chemie. 133(18). 9974–9978. 4 indexed citations
13.
Zhang, Mingxing, Chengyu Liang, Junchang Chen, et al.. (2021). Intrinsic Semiconducting Behavior in a Large Mixed‐Valent Uranium(V/VI) Cluster. Angewandte Chemie International Edition. 60(18). 9886–9890. 51 indexed citations
14.
Yue, Mengkun, Wenfan Yang, Xue Feng, et al.. (2020). Tunable strength of SiCf/β-Yb2Si2O7 interface for different requirements in SiCf/SiC CMC: Inspiration from model composite investigation. Journal of Material Science and Technology. 67. 165–173. 23 indexed citations
15.
Wang, Hongquan, et al.. (2015). Pinocembrin attenuates MPP + -induced neurotoxicity by the induction of heme oxygenase-1 through ERK1/2 pathway. Neuroscience Letters. 612. 104–109. 24 indexed citations
16.
An, Wei, et al.. (2009). GENETIC DIVERSITY IN ANNUAL WILD SOYBEAN (GLYCINE SOJA SIEB. ET ZUCC.) AND CULTIVATED SOYBEAN (G. MAX . MERR.) FROM DIFFERENT LATITUDES IN CHINA. Pakistan Journal of Botany. 41(5). 2229–2242. 6 indexed citations
17.
Zhang, Jingliang, et al.. (2007). Fair E-Cash System without Trustees for Multiple Banks. 585–587. 6 indexed citations
18.
Zhang, Jianhong, et al.. (2005). On the Security of a Digital Signature with Message Recovery Using Self-certified Public Key. International Conference on Applied Mathematics. 29(3). 24–346. 6 indexed citations
19.
Zhang, Jianhong, Qianhong Wu, & Yumin Wang. (2005). A New Efficient Group Signature With Forward Security. Informatica (slovenia). 29(3). 153–157. 3 indexed citations
20.
Wang, Yumin. (2001). Distillation of Unconditionally-Secure Secret-Key Based on Smooth Entropy. Dianzi xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wanpeng Yu Breakdown of academic impact, for papers by Le Su Breakdown of academic impact, for papers by Chao Duan Breakdown of academic impact, for papers by Ning Liu Breakdown of academic impact, for papers by Yihui Yang Breakdown of academic impact, for papers by Min Xu Breakdown of academic impact, for papers by Hui Luo Breakdown of academic impact, for papers by Jifa Zhang
Rankless by CCL
2026